Washington, DC – Today, Representatives Ro Khanna (CA-17), Anthony Brown (MD-04), John Garamendi (CA-03), and Seth Moulton (MA-06) released the following statement after withdrawing an amendment to the FY20 National Defense Authorization Act (NDAA) to prohibit the Trump administration from putting the United States on the path to war with Iran without Congressional authorization.
Washington, DC – Today, Rep. Khanna of the HASC, Budget, and Oversight committees, introduced a series of amendments in the NDAA markup. A summary of the amendments is below:
Washington, DC – Today, Rep. Khanna issued the below statement to provide an update on his work to end U.S. complicity in the war in Yemen.
Santa Clara, Ca. – Today, the Congressional Management Foundation (CMF) announced that Rep.
Silicon Valley – Today, Rep. Khanna of the oversight committee issued the following statement in response to the announcement from Special Counsel Robert S. Mueller III that he was closing his office.
Washington, DC – Rep.
Washington, DC – Today, Rep. Ro Khanna joined a bicameral group of lawmakers in introducing the Opioid Crisis Accountability and Results Act, as Vermont Attorney General T. J. Donovan announced a lawsuit today against former Purdue Pharma CEO Richard Sackler and seven family members who served on Purdue’s Board of Directors for deliberately misrepresenting the risks of the drug OxyContin.
Washington, DC – Tomorrow, Rep. Ro Khanna will chair a hearing titled, “DOD Inspector General Report on Excess Profits by TransDigm Group, Inc.” at 10:00am in 2154 Rayburn HOB in the House Committee on Oversight and Reform.
Today, Rep. Khanna issued the below statement in response to today’s reporting from TIME.
In response to today’s oped in the New York Times by Facebook Co-Founder Chris Hughes, Rep. Khanna issued the below statement: